The cellular delivery of antisense oligonucleotides and ribozymes
- 12 March 2001
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 6 (6) , 303-315
- https://doi.org/10.1016/s1359-6446(00)00326-3
Abstract
No abstract availableKeywords
This publication has 101 references indexed in Scilit:
- Recent developments in hepatitis C antiviral research 1999 - 2000Expert Opinion on Therapeutic Patents, 2000
- Uptake of Liposomes Containing Phosphatidylserine by Liver Cellsin Vivoand by Sinusoidal Liver Cells in Primary Culture:In Vivo–in VitroDifferencesBiochemical and Biophysical Research Communications, 1999
- Brain as a Unique Antisense EnvironmentAntisense and Nucleic Acid Drug Development, 1999
- Characterization of Complexes of Oligonucleotides with Polyamidoamine Starburst Dendrimers and Effects on Intracellular DeliveryJournal of Pharmaceutical Sciences, 1997
- Antisense oligonucleotide delivery to cultured macrophages is improved by incorporation into sustained-release biodegradable polymer microspheresInternational Journal of Pharmaceutics, 1997
- Phosphorothiolate Ribozyme against the Conserved Sequence in V3 Loop of HIV-1Biochemical and Biophysical Research Communications, 1996
- Dendrimer Delivery of OligonucleotidesDrug Delivery, 1996
- Penetration of oligonucleotides into mouse organism through mucosa and skinFEBS Letters, 1993
- Stability of antisense DNA oligodeoxynucleotide analogs in cellular extracts and seraLife Sciences, 1991
- Sequence‐dependent hydrolysis of RNA using modified oligonucleotide splints and RNase HFEBS Letters, 1987